Skip to main content
MSF logo
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Media room
  • Contact
  • msf.org
  • MSF Access
    • About MSF Access
    • Media room
    • Latest news
    • Jobs
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Our work
    • Diabetes
    • Drug-resistant infections
    • Hypertension
    • Patents and intellectual property
      • Pandemic prevention, preparedness and response
      • The Patent Oppositions Database
    • Research and development
      • Spotlight on: the Big Pharma double-dip
      • Transparency Matters: Clinical Trials Costs
    • Tuberculosis
    • Vaccines
    • Other work
      • COVID-19
      • Hepatitis C
      • HIV/AIDS
      • Tropical and neglected diseases
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Get involved
    • Campaign success stories
      • #NoMoreTears Johnson & Johnson Can you hear us?
      • A Fair Shot
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    • Recent campaigns
      • Time for $5
      • No Patents in a Pandemic
      • Share the Tech - Save Lives
    MSF Access Missions Medicines Should Not be a Luxury
    Take Action
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
  • Resources
    • Press releases
    • Statements
    • Letters
    • Opinion articles
    • Feature stories
    • Interviews
    • Blog
    • Newsletters
    • Publications
    • Research articles
    • Topic overview pages
    • Videos
    • Photo stories
    • Infographics
    • Events
    Get Involved!
    Sign up to stay updated and find out how you can get involved.
Medicines shouldn’t be a luxury Take action
Get involved
Our campaigns

Latest Press Releases

Latest Press Releases

Because of COVID-19 MSF has increased its activities in the camp with more comprehensive care staff. Also, the organization has been in touch with immigration and health authorities to have a better understanding and plan of action to be prepared in case a COVID-19 patient is detected.
Press release
Press release |
27 March 2020
COVID-19
MexicoUnited States of America

US must include asylum seekers in COVID-19 response, rather than shut border

covid_spainmsf310469_hero_badelm_2020 Photo by Bad Elm/Olmo Calvo
Press release
Press release |
27 March 2020
COVID-19

MSF calls for no patents or profiteering on COVID-19 drugs, tests, and vaccines in pandemic

4 min
More and more people are wearing masks and gloves while being outside in the streets.
Press release
Press release |
18 March 2020
COVID-19
France

As COVID-19 continues to spread, MSF prepares for action in France

MSF Flag Photograph by Valérie Batselaere
Press release
Press release |
16 March 2020
COVID-19
European Union

COVID-19: Urgent help needed across European borders to protect medical staff

4 min
A general view of the olive grove next to the official camp of Moria. At the moment, 13,000 people stranded in a camp designed to host just 3,000. People in the olive grove have to share their tents with other people with whom, they don’t have any previous relationship. The level of hygiene is very low and people have to share a toilet with another 90 people and a shower with 200. When it rains the tents are getting wet and the area turns into a muddy swamp.
Press release
Press release |
12 March 2020
COVID-19
Greece

Evacuation of squalid Greek camps more urgent than ever over COVID-19 fears

Press release
Press release |
12 March 2020
COVID-19
Italy

MSF starts COVID-19 response activities in four northern Italian hospitals

The pneumonia vaccine from GSK used for vaccination in refugee camps in Greek islands was made available at a special reduced price of US$9 while its retail price is $168 in Greece. Photograph by Sophia Apostolia
Press release
Press release |
29 January 2020
Vaccines

Global vaccines community must urgently support rollout of new more affordable pneumonia vaccine

4 min
MSF protests at Wall Street after J&J announces 2019 sales increase MSF
Press release
Press release |
22 January 2020
Tuberculosis

As J&J release earnings, MSF protests price of lifesaving TB drug

4 min
  • Load More
Navigate
  • About MSF Access
  • Contact us
  • Get involved
  • Our work
  • Resources
  • Search
Get updates
  • Sign up for our newsletter
  • Privacy & data protection information
Contact

MSF Access
Médecins Sans Frontières
140 Route de Ferney
1202 Geneva, Switzerland
Phone:+41 22 849 8484
E-mail: [email protected]

Follow us

  • X
  • Facebook
  • YouTube
  • Medium
Medicines Shouldn't Be A Luxury